Orthopedic practices sit closest to the regenerative opportunity and are often the slowest to move on it. The patients are already in the building, the imaging is already done, the procedural skill already exists. What holds practices back is rarely capability. It is that the surgical business model and the cash-pay business model pull in opposite directions.
For an orthopedic practice, adding regenerative medicine is a positioning decision more than a clinical one. The patients you already turn away — not surgical candidates, not ready for surgery, wanting to avoid it — are the exact regenerative population. The difficulty is building a cash-pay conversion process inside a practice organized around surgical volume and insurance reimbursement.
You Already See the Patients
Every orthopedic practice has a category of patient it cannot help well. The 52-year-old with knee arthritis who is not bad enough for replacement. The patient who is a candidate but refuses. The one whose imaging looks moderate and who has been told to wait and manage it.
Those patients currently leave with an injection, a referral to physical therapy, and instructions to come back in six months. Many of them go home and search for alternatives, and a meaningful number find a regenerative clinic that is not yours.
That is the whole opportunity in one sentence: you are already generating demand for regenerative medicine and sending it elsewhere.
The Credibility Advantage Is Real
Orthopedic practices have something no standalone regenerative clinic can buy: patients already believe you.
The regenerative category has a trust problem, earned through years of overclaiming. Patients arrive skeptical and researching. An orthopedic surgeon offering a conservative option carries authority that no amount of marketing manufactures, particularly when that surgeon is also willing to say who should not do it.
That advantage also cuts the sales cycle. A patient who has already been examined by you, whose imaging you have already reviewed, is not starting from zero the way a cold inquiry is.
The Business Model Conflict Nobody Names
Here is the honest obstacle. A surgical practice is optimized for throughput and reimbursement: see patients efficiently, convert appropriate ones to procedures, bill insurance. Regenerative medicine asks the same practice to slow down, have a long conversation about money, and follow up for weeks.
Those are not just different workflows. They compete for the same clinical hours, and surgery is more lucrative per hour of surgeon time. A practice that treats regenerative medicine as something the surgeon squeezes between cases will do it badly.
The practices that succeed separate the two. The surgeon establishes candidacy and lends authority; a trained coordinator owns the consultation, pricing, and follow-up. Trying to make the surgeon run a five-figure cash-pay sale is the most common failure, and it is a structural mistake rather than a personal one. The role split is covered in our sales team staffing handbook.
Where It Fits Clinically in Your Existing Flow
Position regenerative treatment as a defined step in the conservative pathway rather than an alternative to what you already do.
That framing matters internally as well as externally. Staff who see it as a competing offer will resist it; staff who see it as an option for patients they already could not help will adopt it. It also protects you from the perception that surgery is being steered away from for financial reasons, which is the reputational risk an orthopedic practice carries here that others do not.
Be explicit about who is not a candidate. A practice that continues recommending surgery when surgery is indicated, and offers regenerative treatment only where it genuinely fits, keeps the credibility that makes the whole thing work.
The Referral Network Changes
Orthopedic practices typically receive referrals rather than send them. Adding a cash-pay service line adjusts that flow in ways worth anticipating.
Primary care physicians and chiropractors who currently refer to you for surgical evaluation now have a second reason to refer: the patient who does not want surgery. That expands your inbound pool if you communicate it clearly.
It can also create friction with referrers who are skeptical of the category. Address it the same way you address patients: with candidacy criteria, plain language about evidence, and a willingness to send patients back untreated. Our guide to physician referrals covers the mechanics.
What It Actually Requires
Clinically, less than most practices assume. You have imaging, guidance capability, procedural infrastructure, and sterile workflow. Biologics sourcing and some additional training are the real clinical lines.
Commercially, more than most practices assume. You need someone who owns the patient conversation end to end, a proposal the patient can take home, follow-up that runs for weeks, and a way to attribute revenue back to source. None of that exists in a reimbursement-based practice, and none of it is optional. The full cost picture is in what it costs to add a regenerative medicine service line.
Start Inside the Practice
Do not advertise first. Run a chart review for patients you have already seen and could not help surgically, and start there.
They are warmer, cheaper, and already trust you, and they let you build the consultation process on friendly ground before it costs you acquisition spend. Most orthopedic practices find their existing files hold months of candidates. The method is in introducing regenerative medicine to your existing patients.
Frequently Asked Questions
Will offering regenerative treatment cannibalize surgical volume?
In practice it usually captures patients who were not going to have surgery with you anyway — the ones declining it or not yet indicated. Keep the candidacy criteria clinical and the two populations stay largely separate.
Should the surgeon perform the injections?
Often yes for credibility, though the more important question is whether surgeon time is the best use of the procedure slot. Many practices have a mid-level provider perform routine cases with the surgeon establishing candidacy.
How do we handle patients asking why insurance does not cover it?
Answer directly and move to what they are actually weighing: the cost of surgery, recovery time, and continued conservative management. Defensiveness on this question does more damage than the answer.
What is the biggest mistake orthopedic practices make?
Assuming the clinical familiarity means the business will be familiar too. The procedure is adjacent; the cash-pay conversion process is a different discipline and has to be built deliberately.
Evaluating a regenerative service line? Book a free strategy call.